Protalix BioTherapeutics, Inc.
PLX· NYSE
Released Mar 12, 2015, after the close
10-K filed Mar 12, 2015, 71 days after period end · 0001144204-15-015672
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $1.17M | $2.36M |
| Net Income | -$8.47M | -$10.89M | -$9.88M |
Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR
| -$8.91M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.